King’s College London has today been awarded £10,164,789 by the HEFCE-managed UK Research Partnership Investment Fund (UKRPIF) to establish a world-class Advanced Therapies Centre at Guy’s and St Thomas’ NHS Foundation Trust.

The Centre, which is also supported by £20 million in funding from private sector and non-profit organisations, will develop cutting-edge experimental treatments with the aim of revolutionising the way patients all over the world are treated for diseases like cancer and diabetes.

Bringing together world-leading academics and clinicians, drug manufacturing capability and experimental medicine research facilities, the Advanced Therapies Centre will be developed by King’s College London in partnership with the National Institute for Health Research (NIHR) Biomedical Research Centre at Guy’s and St Thomas’ and King’s College London, and is expected to open in 2018.

Professor Sir Robert Lechler, Senior Vice President and Provost (Health) of King’s College London and Executive Director of King’s Health Partners Academic Health Science Centre, said: “Advanced therapies offer enormous promise for patients suffering from severe and incurable conditions. This new Centre will provide our world-leading scientists with the facilities they need to make breakthroughs in the global fight against a wide range of diseases.”

The Advanced Therapies Centre will occupy two floors of Guy’s Hospital Tower, increasing the size of Guy’s and St Thomas’ Experimental Medicine Hub from 10 to 12 floors of the Tower.

Amanda Pritchard, Chief Executive of Guy’s and St Thomas’ NHS Foundation Trust said: “The new Advanced Therapies Centre, along with the facilities and expertise of our NIHR Biomedical Research Centre, will enable our clinical teams and their academic colleagues to lead the search for new and better personalised treatments for patients with conditions such as cancer and diabetes.”

In addition to the UKRPIF award, the Centre also received £20million of support from GSK, Cellectis, the Innovate UK Cell & Gene Therapy Catapult, and the Charité Research Organisation.

Universities and Science Minister Jo Johnson said: “The UK’s world-renowned leadership in science, research and innovation is helping to solve a range of national and global challenges, and the breadth of the projects funded today means this will continue.

“Through our Industrial Strategy and £4.7 billion investment for research and development, we’re ensuring we capitalise on the great work taking place in universities across the UK and remain at the forefront of innovation.”

Managed by the Higher Education Funding Council for England (HEFCE), in collaboration with the UK higher education funding bodies in Scotland, Wales and Northern Ireland, UKRPIF supports higher education research in areas of research excellence to attract investment, and to strengthen the contribution of research to the economy. Proposals are assessed by an independent panel.